157 related articles for article (PubMed ID: 30610812)
21. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
22. Bilateral primary breast cancers: a clinicopathological study of the second primary.
Awad AT; el-Husseini G; Anwar M; Abu-Nasr A; Anwar AA; Sakr M
Int Surg; 1996; 81(1):57-60. PubMed ID: 8803708
[TBL] [Abstract][Full Text] [Related]
23. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
24. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
[TBL] [Abstract][Full Text] [Related]
25. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.
Aydiner A; Karadeniz A; Uygun K; Tas S; Tas F; Disci R; Topuz E
Am J Clin Oncol; 2000 Aug; 23(4):364-70. PubMed ID: 10955865
[TBL] [Abstract][Full Text] [Related]
26. Associated primary tumors in patients with gastric cancer.
Dinis-Ribeiro M; Lomba-Viana H; Silva R; Moreira-Dias L; Lomba-Viana R
J Clin Gastroenterol; 2002; 34(5):533-5. PubMed ID: 11960064
[TBL] [Abstract][Full Text] [Related]
27. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
28. Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study.
Ławniczak M; Gawin A; Jaroszewicz-Heigelmann H; Rogoza-Mateja W; Raszeja-Wyszomirska J; Białek A; Karpińska-Kaczmarczyk K; Starzyńska T
World J Gastroenterol; 2014 Jun; 20(23):7480-7. PubMed ID: 24966619
[TBL] [Abstract][Full Text] [Related]
29. Multiple primary malignancies--a retrospective analysis at a single center in Turkey.
Arpaci E; Tokluoglu S; Yetigyigit T; Alkis N
Asian Pac J Cancer Prev; 2013; 14(2):769-73. PubMed ID: 23621235
[TBL] [Abstract][Full Text] [Related]
30. Multiple primary cancers in patients with gastric cancer.
Wu CW; Lo SS; Chen JH; Hsieh MC; Li AF; Lui WY
Hepatogastroenterology; 2006; 53(69):463-7. PubMed ID: 16795993
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological features of and risk factors for multiple primary melanomas.
Ferrone CR; Ben Porat L; Panageas KS; Berwick M; Halpern AC; Patel A; Coit DG
JAMA; 2005 Oct; 294(13):1647-54. PubMed ID: 16204664
[TBL] [Abstract][Full Text] [Related]
32. Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.
Friedrich RE
Anticancer Res; 2007; 27(4A):1805-18. PubMed ID: 17649777
[TBL] [Abstract][Full Text] [Related]
33. Multiple primary malignant neoplasms: A 10-year experience at a single institution from Turkey.
Etiz D; Metcalfe E; Akcay M
J Cancer Res Ther; 2017; 13(1):16-20. PubMed ID: 28508827
[TBL] [Abstract][Full Text] [Related]
34. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
36. Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors.
Ibrahim NY; Sroor MY; Darwish DO
Asian Pac J Cancer Prev; 2015; 16(3):1007-10. PubMed ID: 25735321
[TBL] [Abstract][Full Text] [Related]
37. Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.
Vadgaonkar RA; Nayak SS; Doni S; Digumarti L; Mullapally SK; Digumarti R
Indian J Pathol Microbiol; 2021; 64(4):725-731. PubMed ID: 34673592
[TBL] [Abstract][Full Text] [Related]
38. Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998.
Howe HL; Weinstein R; Alvi R; Kohler B; Ellison JH
Breast Cancer Res Treat; 2005 Apr; 90(3):223-32. PubMed ID: 15830135
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
40. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites.
Erkal HS; Mendenhall WM; Amdur RJ; Villaret DB; Stringer SP
J Clin Oncol; 2001 Mar; 19(5):1358-62. PubMed ID: 11230479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
